2018 - Recent FDA Auditing Practices and the Top 10 Most Common Cited GMP Deficiencies
Date2018-09-26
Deadline2018-09-25
VenueOnline event, USA - United States
KeywordsFDA auditing practices; FDA warning letters 483; FDA enforcement actions
Topics/Call fo Papers
Changes in FDA audit approaches
Most common cited GMP drug deficiencies for 2012-2015
Increase in FDA enforcement actions
How best to address FDA 483 observations when received
Most common cited GMP drug deficiencies for 2012-2015
Increase in FDA enforcement actions
How best to address FDA 483 observations when received
Other CFPs
- Anti-Kickback, Fraud, Stark, and Marketing - Where are the Landmines?
- The PROSPER Act: Its Potential Impact on Higher Education and the Survival of Colleges and Universities
- CGMP controlled Raw Materials
- Hematology Conferences 2018 | Hematology Events | Blood Disorders Conference | Meetings | Global Events | Europe
- ICEMI 2018 - 2018 3rd International Conference on Economics and Management Innovations
Last modified: 2018-06-16 00:57:46